Axl Ccl19 Bmp-6 Wound Healing Patent, Apr 15
Summary
The European Patent Office published application EP3768300A1 on April 15, 2026, covering the use of AXl, CCL19 and/or BMP-6 for promoting wound healing. The applicant is Imperial College Innovations Limited, with inventors Helena TOPOUZI and Claire HIGGINS. The application is classified under A61K 38/45 among other IPC codes and designates multiple European contracting states including AT, BE, DE, DK, ES, FI, FR, GB, IT, NL, NO, PL, SE, and others.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO published European patent application EP3768300A1 for Imperial College Innovations Limited, covering therapeutic methods using AXl, CCL19 and/or BMP-6 to promote wound healing. The application names Helena TOPOUZI and Claire HIGGINS as inventors and designates numerous European contracting states.
Pharmaceutical companies and healthcare providers developing wound-healing therapeutics should review this patent landscape to assess potential freedom-to-operate implications for similar therapeutic approaches involving these specific molecular targets.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
USE OF AXL, CCL19 AND/OR BMP-6 FOR PROMOTING WOUND HEALING
Publication EP3768300A1 Kind: A1 Apr 15, 2026
Applicants
Imperial College Innovations Limited
Inventors
TOPOUZI, Helena, HIGGINS, Claire
IPC Classifications
A61K 38/45 20060101AFI20260311BHEP A61K 38/18 20060101ALI20260311BHEP A61L 15/44 20060101ALI20260311BHEP A61P 17/02 20060101ALI20260311BHEP A61K 38/19 20060101ALI20260311BHEP A61F 13/00 20060101ALI20260311BHEP A61K 8/60 20060101ALI20260311BHEP A61K 8/64 20060101ALI20260311BHEP A61Q 19/00 20060101ALI20260311BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.